| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_026757b69067043dfb3433a00021fcb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93970efbfe7933d6a3a2b73fda5fdd77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ba9a8cc358070bad9b84816ce46abbf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate |
2009-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951643bb5a7cc93c66cc66625ba55c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976808396274aca831847fff466af2e9 |
| publicationDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010015567-A2 |
| titleOfInvention |
Controlled release formulations using intelligent polymers |
| abstract |
A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652527-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9101545-B2 |
| priorityDate |
2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |